About BFS Molecular
BFS Molecular is a company based in Budapest (Hungary) founded in 2017 was acquired by CareDx in March 2021.. BFS Molecular offers products and services including Molecular Solutions. BFS Molecular operates in a competitive market with competitors including Oxford Immunotec, Immucor, Verici Dx, Olaris and Nephrosant, among others.
- Headquarter Budapest, Hungary
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BFS Molecular
BFS Molecular offers a comprehensive portfolio of products and services, including Molecular Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides pioneering molecular innovations for user applications and updates.
Funding Insights of BFS Molecular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BFS Molecular
BFS Molecular has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CareDx. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical solutions for transplant patients are developed and provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BFS Molecular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BFS Molecular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bfs Molecular Comparisons
Competitors of BFS Molecular
BFS Molecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Immunotec, Immucor, Verici Dx, Olaris and Nephrosant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Transfusion and transplantation diagnostic products are provided by Immucor.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic solutions for organ transplants
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic solutions for kidney disorders
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic tests for early graft injury detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bfs Molecular
Frequently Asked Questions about BFS Molecular
When was BFS Molecular founded?
BFS Molecular was founded in 2017.
Where is BFS Molecular located?
BFS Molecular is headquartered in Budapest, Hungary.
What does BFS Molecular do?
Developer of diagnostics for post-transplantation care. The products include StemScan that detects post-transplant chimerism for hematopoietic stem cell transplant, OrganScan that detects donor-derived DNA post-transplant for a solid organ transplant, and Graftrack software for both the products to monitor the result. These diagnostics are based on next-generation sequencing technology.
Who are the top competitors of BFS Molecular?
BFS Molecular's top competitors include Olaris, Oxford Immunotec and Verici Dx.
What products or services does BFS Molecular offer?
BFS Molecular offers Molecular Solutions.
Who are BFS Molecular's investors?
BFS Molecular has 1 investor. Key investors include CareDx.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.